Article History
Received: 28 June 2021
Accepted: 10 November 2021
First Online: 24 November 2021
Declarations
:
: Ethical approval for this study was provided by the Research Ethics Committee of Sun Yat-sen University Cancer Center (Chairperson Prof. Wangqing Peng) on 5 June 2018. Written informed consent was obtained from all patients participating in the trial. The study was registered at a clinical trials registry (, registered number: ChiCTR1800016790), and was conducted at the Sun Yat-sen University Cancer Center from June 2018 to November 2018. Our methodology followed the international guidelines for observational studies.
: Written informed consent for publication was obtained from all participants.
: The authors declare that they have no competing interests.